Literature DB >> 16932650

Mechanisms of disease: is osteoporosis the obesity of bone?

Clifford J Rosen1, Mary L Bouxsein.   

Abstract

Osteoporosis and obesity, two disorders of body composition, are growing in prevalence. Interestingly, these diseases share several features including a genetic predisposition and a common progenitor cell. With aging, the composition of bone marrow shifts to favor the presence of adipocytes, osteoclast activity increases, and osteoblast function declines, resulting in osteoporosis. Secondary causes of osteoporosis, including diabetes mellitus, glucocorticoids and immobility, are associated with bone-marrow adiposity. In this review, we ask a provocative question: does fat infiltration in the bone marrow cause low bone mass or is it a result of bone loss? Unraveling the interface between bone and fat at a molecular and cellular level is likely to lead to a better understanding of several diseases, and to the development of drugs for both osteoporosis and obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932650     DOI: 10.1038/ncprheum0070

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  345 in total

1.  Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice.

Authors:  Ganesh V Halade; Amina El Jamali; Paul J Williams; Roberto J Fajardo; Gabriel Fernandes
Journal:  Exp Gerontol       Date:  2010-10-12       Impact factor: 4.032

2.  Tissue-specific expression of Sprouty1 in mice protects against high-fat diet-induced fat accumulation, bone loss and metabolic dysfunction.

Authors:  Sumithra Urs; Terry Henderson; Phuong Le; Clifford J Rosen; Lucy Liaw
Journal:  Br J Nutr       Date:  2011-12-06       Impact factor: 3.718

3.  The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years.

Authors:  E T Middleton; S A Steel; M Aye; S M Doherty
Journal:  Osteoporos Int       Date:  2011-01-28       Impact factor: 4.507

4.  Increased marrow adiposity in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; David W Dempster; Emily M Stein; Thomas L Nickolas; Hua Zhou; Donald J McMahon; Ralph Müller; Thomas Kohler; Alexander Zwahlen; Joan M Lappe; Polly Young; Robert R Recker; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2012-06-14       Impact factor: 5.958

Review 5.  Denosumab: anti-RANKL antibody.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

Review 6.  Fat-bone interaction within the bone marrow milieu: Impact on hematopoiesis and systemic energy metabolism.

Authors:  C P Hawkes; S Mostoufi-Moab
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

7.  Association between dietary fat intake and bone mineral density in Korean adults: data from Korea National Health and Nutrition Examination Survey IV (2008 ∼ 2009).

Authors:  Y-M Kwon; G W Kim; H W Yim; Y J Paek; K-S Lee
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

8.  Soy protein isolate inhibits high-fat diet-induced senescence pathways in osteoblasts to maintain bone acquisition in male rats.

Authors:  Jin-Ran Chen; Oxana P Lazarenko; Michael L Blackburn; Thomas M Badger; Martin J J Ronis
Journal:  Endocrinology       Date:  2014-12-09       Impact factor: 4.736

9.  Identification of Phf16 and Pnpla3 as new adipogenic factors regulated by phytochemicals.

Authors:  Seo-Hyuk Chang; Ui Jeong Yun; Jin Hee Choi; Suji Kim; A Reum Lee; Dong Ho Lee; Min-Ju Seo; Vanja Panic; Claudio J Villanueva; No-Joon Song; Kye Won Park
Journal:  J Cell Biochem       Date:  2018-09-11       Impact factor: 4.429

10.  Deletion of PPARγ in Mesenchymal Lineage Cells Protects Against Aging-Induced Cortical Bone Loss in Mice.

Authors:  Jay Cao; Kehong Ding; Guodong Pan; Raysa Rosario; Yun Su; Yonggang Bao; Hongyan Zhou; Jianru Xu; Meghan E McGee Lawrence; Mark W Hamrick; Carlos M Isales; Xingming Shi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-04-17       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.